The acquisition of Ultradent in the United States has been completed. Approvals and filings with competition authorities and investment regulators were completed earlier than expected, and the company announced a plan to transfer the global headquarters function for the oral care business from Japan to a U.S. holding company. The impact on consolidated results is under review.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4183","jir_company_name":"Mitsui Chemicals, Incorporated","jir_importance":"\u2605\u2605\u2605\u2606\u2606","jir_publication_date":"2026-08-17","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/08\/4183-20260817-01.pdf","jir_short_summary":"The acquisition of Ultradent in the United States has been completed. Approvals and filings with competition authorities and investment regulators were completed earlier than expected, and the company announced a plan to transfer the global headquarters function for the oral care business from Japan to a U.S. holding company. The impact on consolidated results is under review.","jir_summary":"### Section Heading\nThis is a notice reporting the completion of the acquisition of Ultradent in the United States. As a prerequisite, disclosures regarding the signing of the acquisition agreement and the establishment of a new company have been made, and the acquisition procedures were completed today. It explains that approvals and filings with authorities regarding competition law and the Investment Control Act were completed earlier than anticipated. The plan is to transfer the global headquarters function for the oral care business from Japan to a U.S. holding company upon acquisition, aiming to maximize group-wide integration effects and to become a leading company. It is explicitly stated that the impact on consolidated results is under review.\n\n### Section 2\nFuture schedules and the formal disclosure of financial impacts are undecided. Additional information on the integration effects, implementation status, and financial impact after the acquisition will be disclosed as appropriate.","jir_financial_highlights":"Revenue: Unknown (Unknown)\nAcquisition amount: Unknown (Unknown)","jir_category":"","jir_hashtags":"","jir_key_figures":"Acquisition completion date: 2026-08-14 (local time)\nSpecific amount related to the acquisition: Unknown\nNew group structure: Transfer of the oral care business's global headquarters function from Japan to a U.S. holding company","jir_meta_title":"Mitsui Chemicals - Ultradent Acquisition Procedures Completed | August 2026","jir_meta_description":"Mitsui Chemicals announces the completion of the Ultradent acquisition procedures in the United States. Approvals from competition authorities and investment regulators came earlier than expected, accelerating global integration of the oral care business. The impact on Consolidated results is under review.","jir_og_title":"Mitsui Chemicals - Ultradent Acquisition Procedures Completed | August 2026","jir_og_description":"Acquisition procedures for Ultradent completed. Aiming to transfer the global headquarters function and maximize integration effects; however, financial impact remains undecided.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":7672,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"corporate_restructuring","footnotes":""},"sector":[],"importance":[],"class_list":["post-104517","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n